CoChat
Sign Up
Cited by 115

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.

Pera, Marta, Alcolea, Daniel, Sánchez-Valle, Raquel, Guardia-Laguarta, Cristina, Colom-Cadena, Martí, Badiola, Nahuai, Suárez-Calvet, Marc, Lladó, Albert, Barrera-Ocampo, Alvaro A., Sepulveda-Falla, Diego, Blesa, Rafael, Molinuevo, José L., Clarimón, Jordi, Ferrer, Isidre, Gelpi, Ellen, Lleó, Alberto·2013·Acta Neuropathologica
DOI 10.1007/s00401-012-1062-9PMC PMC3623032
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-012-1062-9

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Alafuzoff I, Pikkarainen M, Arzberger T, Thal DR, Al-Sarraj S, Bell J, Bodi I, Budka H, Capetillo-Zarate E, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Stadelmann C, Streichenberger N, Tagliavini F, Kretzschmar H (2008) Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium. Acta Neuropathol 115(5):533–546. doi: 10.1007/s00401-008-0358-2 · DOI
  2. Armstrong J, Boada M, Rey MJ, Vidal N, Ferrer I (2004) Familial Alzheimer disease associated with A713T mutation in APP. Neurosci Lett 370(2–3):241–243. doi: 10.1016/j.neulet.2004.08.026 · DOI
  3. Balasa M, Vidal-Pineiro D, Llado A, Antonell A, Bosch B, Castellanos F, Bargallo N, Bartres-Faz D, Molinuevo JL, Sanchez-Valle R (2012) PSEN1 mutation carriers present lower cerebrospinal fluid amyloid-β42 levels than sporadic early-onset Alzheimer’s disease patients but no differences in neuronal injury biomarkers. J Alzheimers Dis 30(3):605–616. doi: 10.3233/JAD-2012-111949 · DOI
  4. Berezovska O, Lleo A, Herl LD, Frosch MP, Stern EA, Bacskai BJ, Hyman BT (2005) Familial Alzheimer’s disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J Neurosci 25(11):3009–3017 · DOI
  5. Cai Y, Xiong K, Zhang XM, Cai H, Luo XG, Feng JC, Clough RW, Struble RG, Patrylo PR, Chu Y, Kordower JH, Yan XX (2010) β-Secretase-1 elevation in aged monkey and Alzheimer’s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and beta-amyloid accumulation. Eur J Neurosci 32(7):1223–1238. doi: 10.1111/j.1460-9568.2010.07376.x · DOI
  6. Citron M (2010) Alzheimer’s disease: strategies for disease modification. Nat Rev Drug Discov 9(5):387–398. doi: 10.1038/nrd2896 · DOI
  7. Coma M, Guix FX, Ill-Raga G, Uribesalgo I, Alameda F, Valverde MA, Munoz FJ (2008) Oxidative stress triggers the amyloidogenic pathway in human vascular smooth muscle cells. Neurobiol Aging 29(7):969–980. doi: 1016/j.neurobiolaging.2007.01.009 · DOI
  8. Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 88(17):7552–7556 · DOI
  9. Chau DM, Crump CJ, Villa JC, Scheinberg DA, Li YM (2012) Familial Alzheimer disease Presenilin-1 mutations alter the active site conformation of gamma-secretase. J Biol Chem. doi: 10.1074/jbc.M111.300483 · DOI
  10. Chavez-Gutierrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M, Lismont S, Zhou L, Van Cleynenbreugel S, Esselmann H, Wiltfang J, Serneels L, Karran E, Gijsen H, Schymkowitz J, Rousseau F, Broersen K, De Strooper B (2012) The mechanism of gamma-secretase dysfunction in familial Alzheimer disease. EMBO J 31(10):2261–2274. doi: 10.1038/emboj.2012.79 · DOI · Paper page
  11. Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S, Serneels L, Camacho IE, Marjaux E, Craessaerts K, Roebroek AJ, Schwake M, D’Hooge R, Bach P, Kalinke U, Moechars D, Alzheimer C, Reiss K, Saftig P, De Strooper B (2005) Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem 280(35):30797–30806. doi: 10.1074/jbc.M505249200 · DOI
  12. Fortea J, Llado A, Bosch B, Antonell A, Oliva R, Molinuevo JL, Sanchez-Valle R (2010) Cerebrospinal fluid biomarkers in Alzheimer’s disease families with PSEN1 mutations. Neurodegener Dis 8(4):202–207 · DOI
  13. Fortea J, Llado A, Clarimon J, Lleo A, Oliva R, Peri J, Pintor L, Yague J, Blesa R, Molinuevo JL, Sanchez-Valle R (2011) PICOGEN: five years experience with a genetic counselling program for dementia. Neurologia 26(3):143–149 · DOI
  14. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59(9):1381–1389 pii:noc20210 · DOI · Paper page
  15. Ghiso J, Tagliavini F, Timmers WF, Frangione B (1989) Alzheimer’s disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: immunohistochemical and biochemical characterization. Biochem Biophys Res Commun 163(1):430–437 pii:0006-291X(89)92154-2 · DOI
  16. Giliberto L, Borghi R, Piccini A, Mangerini R, Sorbi S, Cirmena G, Garuti A, Ghetti B, Tagliavini F, Mughal MR, Mattson MP, Zhu X, Wang X, Guglielmotto M, Tamagno E, Tabaton M (2009) Mutant presenilin 1 increases the expression and activity of BACE1. J Biol Chem 284(14):9027–9038. doi: 10.1074/jbc.M805685200 · DOI
  17. Guardia-Laguarta C, Pera M, Clarimon J, Molinuevo JL, Sanchez-Valle R, Llado A, Coma M, Gomez-Isla T, Blesa R, Ferrer I, Lleo A (2010) Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol 69(1):53–59 · DOI
  18. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356. doi: 10.1126/science.1072994297/5580/353 · DOI · Paper page
  19. Hata S, Fujishige S, Araki Y, Taniguchi M, Urakami K, Peskind E, Akatsu H, Araseki M, Yamamoto K, Martins RN, Maeda M, Nishimura M, Levey A, Chung KA, Montine T, Leverenz J, Fagan A, Goate A, Bateman R, Holtzman DM, Yamamoto T, Nakaya T, Gandy S, Suzuki T (2011) Alternative processing of gamma-secretase substrates in common forms of mild cognitive impairment and Alzheimer’s disease: evidence for gamma-secretase dysfunction. Ann Neurol 69(6):1026–1031 · DOI
  20. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 105(17):6415–6420. doi: 10510.1073/pnas.0710263105 · DOI · Paper page
  21. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer’s disease. Ann Neurol 51(6):783–786. doi: 10.1002/ana.10208 · DOI · Paper page
  22. Ishii T, Kametani F, Haga S, Sato M (1989) The immunohistochemical demonstration of subsequences of the precursor of the amyloid A4 protein in senile plaques in Alzheimer’s disease. Neuropathol Appl Neurobiol 15(2):135–147 · DOI
  23. Jiang Y, Mullaney KA, Peterhoff CM, Che S, Schmidt SD, Boyer-Boiteau A, Ginsberg SD, Cataldo AM, Mathews PM, Nixon RA (2010) Alzheimer’s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci USA 107(4):1630–1635. doi: 10.1073/pnas.0908953107 · DOI
  24. Joachim C, Games D, Morris J, Ward P, Frenkel D, Selkoe D (1991) Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques. Am J Pathol 138(2):373–384
  25. Kim HS, Kim EM, Lee JP, Park CH, Kim S, Seo JH, Chang KA, Yu E, Jeong SJ, Chong YH, Suh YH (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J 17(13):1951–1953. doi: 10.1096/fj.03-0106fje03-0106fje · DOI · Paper page
  26. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon RA (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141(7):1146–1158. doi: 10.1016/j.cell.2010.05.008 · DOI · Paper page
  27. Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Burger K, Hampel H, Frolich L, Wolf S, Prinz B, Jahn H, Luckhaus C, Perneczky R, Hull M, Schroder J, Kessler H, Pantel J, Gertz HJ, Klafki HW, Kolsch H, Reulbach U, Esselmann H, Maler JM, Bibl M, Kornhuber J, Wiltfang J (2010) Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer’s disease: a multicenter study. Mol Psychiatry 15(2):138–145. doi: 10.1038/mp.2008.84 · DOI
  28. Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, Beach T, Sue L, Sabbagh M, Cai H, Wong P, Price D, Shen Y (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer’s disease patients. Proc Natl Acad Sci USA 101(10):3632–3637. doi: 10.1073/pnas.02056891010205689101 · DOI
  29. Llado A, Sanchez-Valle R, Rey MJ, Mercadal P, Almenar C, Lopez-Villegas D, Fortea J, Molinuevo JL (2010) New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer’s disease. Neurologia 25(1):13–16 · DOI
  30. Lleo A, Blesa R, Queralt R, Ezquerra M, Molinuevo JL, Pena-Casanova J, Rojo A, Oliva R (2002) Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. Arch Neurol 59(11):1759–1763 · DOI
  31. Lleo A, Saura CA (2011) Gamma-secretase substrates and their implications for drug development in Alzheimer’s disease. Curr Top Med Chem 11(12):1513–1527 pii:BSP/CTMC/E-Pub/-000130-11-16 · DOI
  32. McPhie DL, Lee RK, Eckman CB, Olstein DH, Durham SP, Yager D, Younkin SG, Wurtman RJ, Neve RL (1997) Neuronal expression of beta-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid beta and cytoplasmic domains. J Biol Chem 272(40):24743–24746 · DOI
  33. Mitani Y, Yarimizu J, Saita K, Uchino H, Akashiba H, Shitaka Y, Ni K, Matsuoka N (2012) Differential Effects between gamma-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice. J Neurosci 32(6):2037–2050. doi: 10.1523/JNEUROSCI.4264-11.2012 · DOI · Paper page
  34. Nixon RA, Yang DS (2011) Autophagy failure in Alzheimer’s disease—locating the primary defect. Neurobiol Dis 43(1):38–45. doi: 10.1016/j.nbd.2011.01.021 · DOI · Paper page
  35. Oster-Granite ML, McPhie DL, Greenan J, Neve RL (1996) Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J Neurosci 16(21):6732–6741 · DOI · Paper page
  36. Perry G, Lipphardt S, Mulvihill P, Kancherla M, Mijares M, Gambetti P, Sharma S, Maggiora L, Cornette J, Lobl T et al (1988) Amyloid precursor protein in senile plaques of Alzheimer disease. Lancet 2(8613):746 · DOI
  37. Portelius E, Andreasson U, Ringman JM, Buerger K, Daborg J, Buchhave P, Hansson O, Harmsen A, Gustavsson MK, Hanse E, Galasko D, Hampel H, Blennow K, Zetterberg H (2010) Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer’s disease. Mol Neurodegener 5:2. doi: 10.1186/1750-1326-5-2 · DOI
  38. Portelius E, Fortea J, Molinuevo JL, Gustavsson MK, Andreasson U, Sanchez-Valle R (2012) The amyloid-beta isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer’s disease. Mol Med Report 5(4):1111–1115. doi: 10.3892/mmr.2012.774 · DOI
  39. Preece P, Virley DJ, Costandi M, Coombes R, Moss SJ, Mudge AW, Jazin E, Cairns NJ (2003) Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer’s disease. Brain Res Mol Brain Res 116(1–2):155–158 pii:S0169328X0300233X · DOI
  40. Rosen C, Andreasson U, Mattsson N, Marcusson J, Minthon L, Andreasen N, Blennow K, Zetterberg H (2012) Cerebrospinal fluid profiles of amyloid beta-related biomarkers in alzheimer’s disease. Neuromolecular Med 14(1):65–73. doi: 10.1007/s12017-012-8171-4 · DOI
  41. Russo C, Schettini G, Saido TC, Hulette C, Lippa C, Lannfelt L, Ghetti B, Gambetti P, Tabaton M, Teller JK (2000) Presenilin-1 mutations in Alzheimer’s disease. Nature 405(6786):531–532. doi: 10.1038/35014735 · DOI
  42. Sastre M, Dewachter I, Rossner S, Bogdanovic N, Rosen E, Borghgraef P, Evert BO, Dumitrescu-Ozimek L, Thal DR, Landreth G, Walter J, Klockgether T, van Leuven F, Heneka MT (2006) Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proc Natl Acad Sci USA 103(2):443–448. doi: 10.1073/pnas.0503839103 · DOI · Paper page
  43. Sepulveda-Falla D, Glatzel M, Lopera F (2012) Phenotypic profile of early-onset familial alzheimer’s disease caused by presenilin-1 E280A mutation. J Alzheimers Dis 32(1):1–12. doi: 10.3233/JAD-2012-120907 · DOI · Paper page
  44. Sepulveda-Falla D, Matschke J, Bernreuther C, Hagel C, Puig B, Villegas A, Garcia G, Zea J, Gomez-Mancilla B, Ferrer I, Lopera F, Glatzel M (2011) Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer’s disease. Brain Pathol 21(4):452–463. doi: 10.1111/j.1750-3639.2010.00469.x · DOI · Paper page
  45. Shepherd C, McCann H, Halliday GM (2009) Variations in the neuropathology of familial Alzheimer’s disease. Acta Neuropathol 118(1):37–52. doi: 10.1007/s00401-009-0521-4 · DOI
  46. Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10(3):279–288 pii:S0969996102905152 · DOI · Paper page
  47. Tian Y, Bustos V, Flajolet M, Greengard P (2011) A small-molecule enhancer of autophagy decreases levels of Aβ and APP-CTF via Atg5-dependent autophagy pathway. FASEB J 25(6):1934–1942. doi: 10.1096/fj.10-175158 · DOI
  48. Yamada K, Cirrito JR, Stewart FR, Jiang H, Finn MB, Holmes BB, Binder LI, Mandelkow EM, Diamond MI, Lee VM, Holtzman DM (2011) In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci 31(37):13110–13117. doi: 10.1523/JNEUROSCI.2569-11.2011 · DOI · Paper page
  49. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L, Wong P, Price D, Li R, Shen Y (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9(1):3–4. doi: 10.1038/nm0103-3nm0103-3 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Pera, M., Alcolea, D., Sánchez-Valle, R., Guardia-Laguarta, C., Colom-Cadena, M., Badiola, N., Suárez-Calvet, M., Lladó, A., Barrera-Ocampo, A. A., Sepulveda-Falla, D., Blesa, R., Molinuevo, J. L., Clarimón, J., Ferrer, I., Gelpi, E., & Lleó, A.
Venue
Acta Neuropathologica
Publisher
Springer Science and Business Media LLC
Published
2012-12-06
Volume
125
Issue
2
Pages
201-213
ISSN
  • 0001-6322
  • 1432-0533
DOI
10.1007/s00401-012-1062-9
PMC
PMC3623032
Cited by
115
References
11
Language
en
Licence
creativecommons.org/licenses/by/2.0 (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review